[Effect of a platelet activating factor (PAF) antagonist on the hepatic afferent vascular occlusion].
Fukuoka
T
T
Department of Surgery, Nara Medical University.
Nakajima
Y
Y
Matsumoto
M
M
Nakano
H
H
Shiratori
T
T
D000818:Animals; D006504:Hepatic Veno-Occlusive Disease / Q000188:drug therapy*; D008297:Male; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors*; D011726:Pyridinium Compounds / Q000627:therapeutic use*; D051381:Rats; D011919:Rats, Inbred Strains
D010972:Platelet Activating Factor; D011726:Pyridinium Compounds; C053321:CV 6209